// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Anakinra in treatment resistant hospitalised acute polyarticular gout

Richard Haigh - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sepsis

Chloramphenicol

The detrimental side effects of therapeutic glucocorticoids on bone are mediated by their local reactivation by 11β-hydroxysteroid dehydrogenase type 1

Chloe Fenton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

Biopsy proven giant cell arteritis in a patient with psoriatic arthritis on TNF-alpha inhibitor treated with high dose prednisolone and a switch to secukinumab (anti IL-17)

Luke Sammut - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Giant cell arteritis

Prednisolone

Idiopathic hypereosinophilic syndrome as a cause for digital ischaemia in a patient with Raynaud’s phenomenon and ankylosing spondylitis

Owen Cronin - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypereosinophilic Syndrome

N/A

Immunoglobulin G4 related disease with isolated pulmonary involvement in a patient with seropositive rheumatoid arthritis taking adalimumab

Charles Raine - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immunoglobulin G4 related disease

Adalimumab

Rare auto-antibody negative systemic lupus erythematosus: a case report

Alison Kinder - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

A rare case of palmar fasciitis with polyarthritis of ovarian malignancy

Mithun Chakravorty - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiovascular collapse on the ITU! Call the rheumatologist?!

Saadia S Ali - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pyelonephritis

Amoxicillin

Canakinumab use during pregnancy for the treatment of systemic onset juvenile idiopathic arthritis and refractory macrophage activation syndrome

Jessica L Gunn - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Macrophage activation syndrome

canakinumab (SC)

Antiphospholipid syndrome associated withauto immune hearing loss

Taqdees Suhail - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Antiphospholipid syndrome

N/A

Thick and fast: two cases of eosinophilic fasciitis

Raj Amarnani - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Eosinophilic fasciitis

N/A

Fast track giant cell arteritis clinic and pathway for early management of suspected giant cell arteritis: an audit

Faidra Laskou - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Cost effectiveness of a high intensity programme (HIP) compared to a low intensity programme (LIP) for switching patients with rheumatoid arthritis to the etanercept biosimilar

Kavina Shah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Etanercept biosimilar

Peer review in rheumatology members survey

Adam P Croft - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adrenal insufficiency secondary to corticosteroid use: an audit from a UK rheumatology centre

Mark Ford - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Addison's disease

N/A

Significance of occult infections in inflammatory arthritis patients receiving biologic therapies in East London

Ganwa Qadir - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Cardiovascular risk factors are associated with the onset of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in a prospective cohort: EPIC-Norfolk study

Max Yates - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

The association between poor prognostic factors at methotrexate initiation and disease activity and disability over one year: results from the Rheumatoid Arthritis Medication Study

James Gwinnutt - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

The role of US in an atypical presentation of gout

Rosalind Benson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rasburicase in gout complicated by methaemoglobinaemia

Azza Hussein - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout/hyperuricemia

Allopurinol

Copyright © 2026. QuantiNova All rights reserved